Finance News Network

Company Presentations

Invion advances light-activated cancer therapy through early trials

04 July 2025 - CEO Thian Chew highlights strong safety and early efficacy in prostate and skin cancer programs

Inside the Perth Mint

04 July 2025 - A look inside Australia's only government-owned precious metals business

Breakthrough ovarian cancer screening results

01 July 2025 - Study results, regulatory steps and commercial roadmap

A-REIT Investment: A historical perspective and the future outlook

11 June 2025 - Exploring REITs: Structure, strategy and opportunities in a shifting market

Sip & Learn: archTIS, Copper Search, EZZ Life Science Holdings

09 June 2025 - Explore cybersecurity, copper & health

Altech secures full offtake and top green rating for sodium battery rollout

09 May 2025 - Backed by Fraunhofer testing and S&P certification, Altech now eyes funding after securing 100% offtake from industrial buyers.

The future of batteries: What’s next after lithium-ion?

07 May 2025 - Martin Stein discusses the road to safer, more sustainable energy storage and Altech’s vision for next-generation batteries

Full circle: Jim Simpson on Platinum, private credit, and long-horizon investment themes

29 Apr 2025 - Jim Simpson, a co-founder of Platinum Asset Management, walks through investment lessons, current opportunities, and the technologies reshaping tomorrow.

INOVIQ – Delivering targeted cancer treatments

04 Apr 2025 - Next-generation exosome therapy targets solid tumours

Quantum-resistant encryption

21 Mar 2025 - Andrew Wilson, CEO of Senetas (ASX:SEN), discusses the company's encryption technology.

Neuren Pharmaceuticals: Ground-breaking impacts on neurodevelopmental disorders

19 Mar 2025 - Growing DAYBUE and Advancing NNZ-2591

INOVIQ: Advancing Exosome-Based Diagnostics and Therapeutics

19 Mar 2025 - Pioneering Cancer Detection and Treatment

IVE Group: Australia’s largest diversified marketing company

19 Mar 2025 - Strategic Growth Across Marketing and Logistics

Cybersecurity and strategy: Andrew Wilson on Senetas’ latest moves

07 Mar 2025 - Recent sale of Votiro, financial results, and new opportunities

Rural Funds Group cultivates steady growth amid sector expansion

05 Mar 2025 - Diversified agricultural assets and long-term leases drive stability

Prime Financial Group reports strong half-year growth

05 Mar 2025 - Revenue up 25% as acquisitions and wealth management drive performance

Sequoia posts strong first-half results with growth across key divisions

05 Mar 2025 - Investment in technology and strategic acquisitions drive performance

Altech Batteries Pioneering Sustainable Energy Solutions

05 Mar 2025 - Innovative Sodium Chloride Batteries for Grid Storage

Sequoia Financial Group (ASX:SEQ) 1H FY25 results presentation, February 2025

29 Nov 2024 - Sequoia Financial Group (ASX:SEQ) Managing Director and CEO Garry Crole and CFO Lizzie Tan present on the group's first-half FY25 financial results.

IVE Group (ASX:IGL) 1HFY25 results presentation

25 Feb 2025 - Higher margins, cost synergies and strong cash flow drive upgraded profit outlook

Immutep’s therapies move towards late-stage development

19 Feb 2025 - Encouraging trial results support next steps for lead candidate eftilagimod alpha

Alterity Therapeutics advances ATH434 for Multiple System Atrophy

19 Feb 2025 - Phase 2 trial shows promising results in slowing disease progression

Nico Resources advances Wingellina Nickel-Cobalt Project

19 Feb 2025 - Feasibility studies progress as demand for battery metals rises

Australian Foundation Investment Company (ASX:AFI) Half Year Results, January 2025

24 Jan 2025 - CEO and Managing Director Mark Freeman and Portfolio Manager David Grace discuss AFIC's half-year results.

Alterity Therapeutics (ASX:ATH) - Webinar Presentation

29 Nov 2024 - Dr David Stamler - CEO - Alterity Therapeutics Limited (ASX:ATH) is developing first-in-class therapies to treat neurodegenerative disease. The company's lead drug ca…